The global microRNA market, valued at USD 215.4 million in 2019, is witnessing rapid advancements, with a projected CAGR of 13.4% from 2020 to 2027. This growth is driven by the increasing application of microRNAs in disease diagnostics, therapeutic development, and biomarker discovery. By 2027, the market is expected to reach USD 613.2 million, reflecting the growing demand for precision medicine and the increasing focus on molecular research.
The market is expanding due to innovations in RNA-based therapies, advancements in sequencing technologies, and the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders. These factors are contributing to the flourishing demand for microRNA-based solutions.
Discover more insights with the free sample PDF here: https://www.fortunebusinessinsights.com/industry-reports/microrna-market-101237
